Skip to main content
Equibles

Metis Global Partners, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1594916 San Diego, CA
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$5,428,762
+$218,980 QoQ
Shares Held
10,929
-6.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#464
of 1,749 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Metis Global Partners, LLC holds $12,809,533 across 8 Biotechnology names. VRTX ranks #1 (42.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		10,929 $5,428,762
2 RPRX
Royalty Pharma plc
 59,374 $3,329,100
3 REGN
Regeneron Pharmaceuticals, Inc.
 2,439 $1,520,814
4 ALNY
Alnylam Pharmaceuticals, Inc.
 4,009 $1,206,829
5 INCY
Incyte Corp
 4,068 $461,148
6 MRNA
Moderna, Inc.
 6,452 $451,833
7 TECH
BIO-TECHNE Corp
 2,918 $206,156
8 PBYI
Puma Biotechnology, Inc.
 25,264 $204,891

All Filings in VRTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,428,762 10,929
2026-03-31 $5,209,782 11,667
2025-12-31 $5,742,257 12,666
2025-09-30 $5,257,375 13,424
2025-06-30 $6,285,333 14,118
2025-03-31 $7,611,189 15,699
2024-12-31 $5,591,489 13,885
2024-09-30 $6,257,651 13,455
2024-06-30 $5,834,626 12,448
2024-03-31 $5,229,723 12,511
2023-12-31 $5,061,304 12,439
2023-09-30 $4,490,714 12,914
2023-06-30 $4,048,020 11,503
2023-03-31 $3,628,031 11,515
2022-12-31 $2,657,931 9,204
2022-09-30 $1,773,722 6,126
2022-06-30 $1,627,337 5,775
2022-03-31 $1,048,577 4,018
2021-12-31 $496,735 2,262